Emily Shacter, Ph.D., Chief, Laboratory of Biochemistry, Division of Therapeutic Proteins, Office of Biotechnology Products, FDA/CDER/OPS, FDA
R. Graham McCartney, Ph.D., Technical Lead, Biotechnology, Eli Lilly
Jane Robinson, Ph.D., Principal Scientist, Biotherapeutics, National Institute for Biological Standards and Control (NIBSC)
Ruth Cordoba–Rodriguez, Division of Monoclonal Antibodies, Office of Biotechnology Products, Center for Drug Evaluation and Research, FDA
Igor Kaltashov, Ph.D., Associate Professor, Chemistry, University of Massachusetts and Shire Human Genetic Therapies
Nadine M. Ritter, Ph.D., Senior CMC Consultant, Biologics Consulting Group, Inc.
Ewa Marszal, Ph.D., Chemist, Laboratory of Plasma Derivatives, Division of Hematology, CBER, FDA
Xu-Rong Jiang, Ph.D., M.D., Associate Director, Analytical Biochemistry, MedImmune, LLC
Stacey Traviglia, Ph.D., Senior Scientist, Analytical Technology, Biogen Idec, Inc.
Marco Thomann, Ph.D., Group Leader, Development Analytics, Roche Diagnostics GmbH
Philippe-Alexandre Gilbert, Senior Scientist, MedImmune, Inc.
Gillian R. Woollett, M.A., D.Phil., Chief Scientist, Engel & Novitt, LLP
Liming Shi, M.A., M.Sc., Senior Scientist, Bioanalytical Chemistry, Amylin Pharmaceuticals, Inc.
Chris Holloway, Ph.D., Group Director, Regulatory Affairs, ERA Consulting Group
Alain Beck, Ph.D., Head, Physico-Chemistry, Centre d'Immunologie, Pierre Fabre
Ron Taticek, Ph.D., Senior Director and Head, Commercial Product Quality Stewards, Biologics, Genentech, Inc.
Tina S. Morris, Ph.D., Vice President, Biologics and Biotechnology, USP
Aimee Cossins, Ph.D., Group Leader, Analytical & Formulation Development, Syntaxin Ltd.
Ziping Wei, Ph.D., Fellow, Analytical Biochemistry, MedImmune, Inc.
Pat Cash, Senior Director, Analytical Biochemistry, MedImmune, Inc.
Qin Zou, Ph.D., Senior Principal Scientist, Analytical Research & Development, Pfizer, Inc.
Michele K. Dougherty, Ph.D., Product Quality Reviewer, Division of Monoclonal Antibodies, OBP/CDER/FDA
Alain Bernard, Ph.D., Vice President, Biopharmaceutical Process Sciences, UCB Group
John O'Hara, Ph.D., Associate Director, Analytical Development, Biologicals, UCB-Celltech
Kathleen M. Williams, Ph.D., Partner, Intellectual Property, Edwards, Angell, Palmer & Dodge LLP
Brian Harvey, M.D., Ph.D., Vice President, US Regulatory Policy, Global Regulatory Affairs, Sanofi-Aventis
Yung-Hsiang Kao, Ph.D., Senior Scientist & Group Leader, Protein Analytical Chemistry, Genentech, Inc.
Louis-Christian Clauss, Phar.D., IAE, RACS, Antheln Biomed, USA
John T. Stults, Ph.D., Director, Protein Analytical Chemistry-2, Genentech, Inc., a member of the Roche Group
Daniel Higazi, Ph.D., Scientist, Analytical Biochemistry, MedImmune Ltd.
Jette Wypych, Ph.D., Principal Scientist, Process and Product Development, Amgen, Inc.
Alfred Pan, Ph.D., Associate Director, Analytical and Process Technologies, MedImmune, LLC
Paul J. Gil, Ph.D., Deputy Director, Global Regulatory Affairs, Bayer HealthCare
Kirstin Bislev Hansen, M.SC., Senior Regulatory Project Manager, Regulatory Affairs, Marketed Products, Novo Nordisk A/S
Keith Chidwick, Ph.D., Senior Pharmaceutical Assessor, Biologicals Unit, MHRA